Patterns of Failure in Multiple Myeloma with Extramedullary Disease Following Anti-BCMA Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy

被引：0

作者：

Nakashima, J. Y. ^{[1
]}

Khatri, V. ^{[1
]}

Cruz-Chamorro, R. J. ^{[1
]}

Zhou, J. ^{[2
]}

Patra, P. ^{[2
]}

Gonzalez, R. ^{[3
]}

De Avila, G. ^{[3
]}

Locke, F. L. ^{[3
]}

Liu, H. D. ^{[3
]}

Nishihori, T. ^{[3
]}

Puglianini, O. C. ^{[3
]}

Alsina, M. ^{[3
]}

Garjales-Cruz, A. ^{[4
]}

Baz, R. ^{[4
]}

Shah, B. D. ^{[4
]}

Shain, K. ^{[4
]}

Jain, M. D. ^{[3
]}

Hansen, D. ^{[3
]}

Freeman, C. ^{[3
]}

Figura, N. B. ^{[1
]}

机构：

[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Radiat Oncol, Tampa, FL USA

[2] Univ S Florida, Tampa, FL USA

[3] H Lee Moffitt Canc Ctr & Res Inst, Dept Blood & Marrow Transplant & Cellular Immunot, Tampa, FL USA

[4] H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL USA

来源：

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2024年 / 120卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1121

引用

页码：S206 / S207

页数：2

共 50 条

[31] Chimeric antigen receptor T-cell therapy for multiple myeloma
Wang, Zehua
Chen, Chen
Wang, Lei
Jia, Yongxu
Qin, Yanru
FRONTIERS IN IMMUNOLOGY, 2022, 13
[32] Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma
Hosen, Naoki
CANCERS, 2019, 11 (12)
[33] Chimeric antigen receptor T-cell therapy for multiple myeloma
Hosen, Naoki
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2020, 111 (04) : 530 - 534
[34] Chimeric Antigen Receptor T-cell Therapy for Multiple Myeloma
Atrash, Shebli
Ali, Syed Abbas
Usmani, Saad Z.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (01): : 21 - 34
[35] Chimeric antigen receptor T-cell therapy for multiple myeloma
Naoki Hosen
International Journal of Hematology, 2020, 111 : 530 - 534
[36] Cardiovascular events during treatment with anti-BCMA chimeric antigen receptor T-cells in multiple myeloma
Mathilde, Chanut
HEMATOLOGIE, 2023, 29 (05): : 274 - 275
[37] Interventions and Outcomes of Multiple Myeloma Patients Progressing after BCMA-Targeted Chimeric Antigen Receptor (CAR) T-Cell Therapy
Van Oekelen, Oliver
Nath, Karthik
Mouhieddine, Tarek H.
Farzana, Tasmin
Aleman, Adolfo
Melnekoff, David T.
Ghodke-Puranik, Yogita
Jagannath, Sundar
Shah, Urvi A.
Mailankody, Sham
Parekh, Samir
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S428 - S428
[38] COST-EFFECTIVENESS OF ANTI-BCMA CAR T-CELL THERAPY IN TRIPLE-CLASS REFRACTORY MULTIPLE MYELOMA
Barnes, J., I
Frosch, Z. A.
Garfall, A. L.
Vogl, D.
Lin, J.
VALUE IN HEALTH, 2022, 25 (07) : S343 - S343
[39] Overcoming Chimeric Antigen Receptor (CAR) Modified T-Cell Therapy Limitations in Multiple Myeloma
Garcia-Guerrero, Estefania
Sierro-Martinez, Belen
Perez-Simon, Jose Antonio
FRONTIERS IN IMMUNOLOGY, 2020, 11
[40] Development of KITE-585: A Fully Human Anti-BCMA CAR T-Cell Therapy for the Treatment of Multiple Myeloma
Adams, Gregor B.
Feng, Jun
Ghogha, Atefeh
Mardiros, Armen
Murakami, Jodi
Phung, Tammy
Rodriguez, Ruben
Sievers, Stuart
Spindler, Tassja J.
Wiltzius, Jed
Yarka, Clare
Yoder, Sean C.
Polverino, Tony
MOLECULAR THERAPY, 2017, 25 (05) : 133 - 133

← 1 2 3 4 5 →